CN105254649A - 一种盐酸头孢卡品酯的制备方法 - Google Patents
一种盐酸头孢卡品酯的制备方法 Download PDFInfo
- Publication number
- CN105254649A CN105254649A CN201510734485.1A CN201510734485A CN105254649A CN 105254649 A CN105254649 A CN 105254649A CN 201510734485 A CN201510734485 A CN 201510734485A CN 105254649 A CN105254649 A CN 105254649A
- Authority
- CN
- China
- Prior art keywords
- formula
- compound
- compound shown
- diisopropylamine
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 29
- LUXIJPQYUCFVAL-XRLCNELCSA-N 2,2-dimethylpropanoyloxymethyl (6r,7r)-7-[[(z)-2-(2-amino-1,3-thiazol-4-yl)pent-2-enoyl]amino]-3-(carbamoyloxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;hydron;chloride;hydrate Chemical compound O.Cl.N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(=O)OCOC(=O)C(C)(C)C)=O)C(=O)\C(=C/CC)C1=CSC(N)=N1 LUXIJPQYUCFVAL-XRLCNELCSA-N 0.000 title claims abstract description 24
- 229950004627 cefcapene pivoxil Drugs 0.000 title claims abstract description 24
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 107
- 150000001875 compounds Chemical class 0.000 claims abstract description 100
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 claims abstract description 99
- 238000000034 method Methods 0.000 claims abstract description 42
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 claims abstract description 38
- 238000003756 stirring Methods 0.000 claims abstract description 36
- 229940043279 diisopropylamine Drugs 0.000 claims abstract description 33
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims abstract description 24
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims abstract description 24
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000012074 organic phase Substances 0.000 claims abstract description 20
- PELJISAVHGXLAL-UHFFFAOYSA-N iodomethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCI PELJISAVHGXLAL-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 19
- 229910000160 potassium phosphate Inorganic materials 0.000 claims abstract description 19
- 235000011009 potassium phosphates Nutrition 0.000 claims abstract description 19
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims abstract description 11
- WRJWRGBVPUUDLA-UHFFFAOYSA-N chlorosulfonyl isocyanate Chemical compound ClS(=O)(=O)N=C=O WRJWRGBVPUUDLA-UHFFFAOYSA-N 0.000 claims abstract description 10
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 claims abstract description 10
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000006243 chemical reaction Methods 0.000 claims description 60
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 45
- 239000000243 solution Substances 0.000 claims description 23
- NWFNSTOSIVLCJA-UHFFFAOYSA-L copper;diacetate;hydrate Chemical compound O.[Cu+2].CC([O-])=O.CC([O-])=O NWFNSTOSIVLCJA-UHFFFAOYSA-L 0.000 claims description 20
- 238000000605 extraction Methods 0.000 claims description 18
- 229940093916 potassium phosphate Drugs 0.000 claims description 18
- 238000005406 washing Methods 0.000 claims description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 239000012359 Methanesulfonyl chloride Substances 0.000 claims description 9
- 229910019142 PO4 Inorganic materials 0.000 claims description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 9
- 239000007864 aqueous solution Substances 0.000 claims description 9
- 230000003750 conditioning effect Effects 0.000 claims description 9
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 9
- 239000010452 phosphate Substances 0.000 claims description 9
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 7
- 239000008346 aqueous phase Substances 0.000 claims description 7
- 238000000967 suction filtration Methods 0.000 claims description 7
- 238000001291 vacuum drying Methods 0.000 claims description 7
- 238000010511 deprotection reaction Methods 0.000 claims description 3
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract description 20
- 230000001105 regulatory effect Effects 0.000 abstract description 2
- 238000001816 cooling Methods 0.000 abstract 1
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 abstract 1
- 238000009776 industrial production Methods 0.000 abstract 1
- 125000006239 protecting group Chemical group 0.000 abstract 1
- 239000007787 solid Substances 0.000 description 35
- 238000004128 high performance liquid chromatography Methods 0.000 description 25
- 238000010606 normalization Methods 0.000 description 20
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 10
- 150000002148 esters Chemical class 0.000 description 10
- SCNWTQPZTZMXBG-UHFFFAOYSA-N 2-methyloct-2-enoic acid Chemical compound CCCCCC=C(C)C(O)=O SCNWTQPZTZMXBG-UHFFFAOYSA-N 0.000 description 8
- NYZZZGAEPGEDPP-OSXFUQHDSA-N C(C)(C)(C)OC(=O)NC=1SC=C(N1)/C(/C(=O)C1[C@@H]2N(C(=C(C(S2)N)CO)C(=O)O)C1=O)=C/CC Chemical compound C(C)(C)(C)OC(=O)NC=1SC=C(N1)/C(/C(=O)C1[C@@H]2N(C(=C(C(S2)N)CO)C(=O)O)C1=O)=C/CC NYZZZGAEPGEDPP-OSXFUQHDSA-N 0.000 description 8
- 229910052760 oxygen Inorganic materials 0.000 description 8
- 239000001301 oxygen Substances 0.000 description 8
- -1 ester hydrochloride monohydrate Chemical class 0.000 description 7
- 230000036571 hydration Effects 0.000 description 6
- 238000006703 hydration reaction Methods 0.000 description 6
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 6
- XIXNSLABECPEMI-VURMDHGXSA-N (z)-2-[2-[(2-methylpropan-2-yl)oxycarbonylamino]-1,3-thiazol-4-yl]pent-2-enoic acid Chemical compound CC\C=C(/C(O)=O)C1=CSC(NC(=O)OC(C)(C)C)=N1 XIXNSLABECPEMI-VURMDHGXSA-N 0.000 description 5
- PUINLWJOGMZNJT-UHFFFAOYSA-N C(C)(C)NC(C)C.CC(=CCCCCC)C(=O)O Chemical compound C(C)(C)NC(C)C.CC(=CCCCCC)C(=O)O PUINLWJOGMZNJT-UHFFFAOYSA-N 0.000 description 5
- 239000002585 base Substances 0.000 description 5
- 230000032050 esterification Effects 0.000 description 5
- 238000005886 esterification reaction Methods 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 2
- HJJRIJDTIPFROI-NVKITGPLSA-N cefcapene Chemical compound N([C@@H]1C(N2C(=C(COC(N)=O)CS[C@@H]21)C(O)=O)=O)C(=O)\C(=C/CC)C1=CSC(N)=N1 HJJRIJDTIPFROI-NVKITGPLSA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 125000004430 oxygen atom Chemical group O* 0.000 description 2
- 238000010189 synthetic method Methods 0.000 description 2
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- SHRCVUQEWNCLJQ-UHFFFAOYSA-N C(C=CCC)(=O)O.NC=1SC=CN1 Chemical compound C(C=CCC)(=O)O.NC=1SC=CN1 SHRCVUQEWNCLJQ-UHFFFAOYSA-N 0.000 description 1
- 229930186147 Cephalosporin Natural products 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 208000033962 Fontaine progeroid syndrome Diseases 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940059260 amidate Drugs 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- VOAZJEPQLGBXGO-SDAWRPRTSA-N ceftobiprole Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(\C=C/4C(N([C@H]5CNCC5)CC\4)=O)CS[C@@H]32)C(O)=O)=O)=N1 VOAZJEPQLGBXGO-SDAWRPRTSA-N 0.000 description 1
- 229950004259 ceftobiprole Drugs 0.000 description 1
- 229940124587 cephalosporin Drugs 0.000 description 1
- 150000001780 cephalosporins Chemical class 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 238000006482 condensation reaction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- NPUKDXXFDDZOKR-LLVKDONJSA-N etomidate Chemical compound CCOC(=O)C1=CN=CN1[C@H](C)C1=CC=CC=C1 NPUKDXXFDDZOKR-LLVKDONJSA-N 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- LWFWUJCJKPUZLV-UHFFFAOYSA-N n-trimethylsilylacetamide Chemical compound CC(=O)N[Si](C)(C)C LWFWUJCJKPUZLV-UHFFFAOYSA-N 0.000 description 1
- 229940124588 oral cephalosporin Drugs 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Substances [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- 235000015320 potassium carbonate Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- ORIHZIZPTZTNCU-YVMONPNESA-N salicylaldoxime Chemical compound O\N=C/C1=CC=CC=C1O ORIHZIZPTZTNCU-YVMONPNESA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/02—Preparation
- C07D501/04—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510734485.1A CN105254649B (zh) | 2015-11-02 | 2015-11-02 | 一种盐酸头孢卡品酯的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510734485.1A CN105254649B (zh) | 2015-11-02 | 2015-11-02 | 一种盐酸头孢卡品酯的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105254649A true CN105254649A (zh) | 2016-01-20 |
CN105254649B CN105254649B (zh) | 2018-06-26 |
Family
ID=55094632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510734485.1A Active CN105254649B (zh) | 2015-11-02 | 2015-11-02 | 一种盐酸头孢卡品酯的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105254649B (zh) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106083896A (zh) * | 2016-08-23 | 2016-11-09 | 陕西思尔生物科技有限公司 | 一种盐酸头孢卡品酯的制备方法 |
CN106220648A (zh) * | 2016-07-30 | 2016-12-14 | 济南康和医药科技有限公司 | 一种叔丁氧羰基头孢卡品酸二异丙胺盐的合成及纯化方法 |
CN109678887A (zh) * | 2018-12-26 | 2019-04-26 | 湖北凌晟药业有限公司 | 一种盐酸头孢卡品酯中间体bcn的制备方法 |
CN111171050A (zh) * | 2020-03-20 | 2020-05-19 | 毛桃 | 一种盐酸头孢卡品酯的制备方法 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05213968A (ja) * | 1992-02-07 | 1993-08-24 | Shionogi & Co Ltd | デアセチルセファロスポラン酸のカルバモイル化方法 |
WO2008155615A2 (en) * | 2007-06-18 | 2008-12-24 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of cephalosporin antibiotic |
CN101747344A (zh) * | 2009-12-22 | 2010-06-23 | 菏泽睿昌化工有限责任公司 | 盐酸头孢卡品酯的合成方法 |
CN102775425A (zh) * | 2011-05-12 | 2012-11-14 | 华东理工大学 | 一种头孢卡品二异丙胺盐的一锅煮制备方法 |
CN103848851A (zh) * | 2012-11-29 | 2014-06-11 | 上海交通大学 | 一种盐酸头孢卡品酯的合成方法 |
CN104140387A (zh) * | 2013-11-29 | 2014-11-12 | 郑州泰基鸿诺药物科技有限公司 | 一种n-叔丁氧羰基-吖丁啶芳香醚/芳杂环醚类化合物的制备方法 |
-
2015
- 2015-11-02 CN CN201510734485.1A patent/CN105254649B/zh active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05213968A (ja) * | 1992-02-07 | 1993-08-24 | Shionogi & Co Ltd | デアセチルセファロスポラン酸のカルバモイル化方法 |
WO2008155615A2 (en) * | 2007-06-18 | 2008-12-24 | Orchid Chemicals & Pharmaceuticals Limited | An improved process for the preparation of cephalosporin antibiotic |
CN101747344A (zh) * | 2009-12-22 | 2010-06-23 | 菏泽睿昌化工有限责任公司 | 盐酸头孢卡品酯的合成方法 |
CN102775425A (zh) * | 2011-05-12 | 2012-11-14 | 华东理工大学 | 一种头孢卡品二异丙胺盐的一锅煮制备方法 |
CN103848851A (zh) * | 2012-11-29 | 2014-06-11 | 上海交通大学 | 一种盐酸头孢卡品酯的合成方法 |
CN104140387A (zh) * | 2013-11-29 | 2014-11-12 | 郑州泰基鸿诺药物科技有限公司 | 一种n-叔丁氧羰基-吖丁啶芳香醚/芳杂环醚类化合物的制备方法 |
Non-Patent Citations (1)
Title |
---|
JIAN-AN JIANG ET AL.: ""A Practical Synthesis of Cefcapene Pivoxil"", 《SYNTHESIS》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106220648A (zh) * | 2016-07-30 | 2016-12-14 | 济南康和医药科技有限公司 | 一种叔丁氧羰基头孢卡品酸二异丙胺盐的合成及纯化方法 |
CN106220648B (zh) * | 2016-07-30 | 2018-08-31 | 济南康和医药科技有限公司 | 一种叔丁氧羰基头孢卡品酸二异丙胺盐的合成及纯化方法 |
CN106083896A (zh) * | 2016-08-23 | 2016-11-09 | 陕西思尔生物科技有限公司 | 一种盐酸头孢卡品酯的制备方法 |
CN109678887A (zh) * | 2018-12-26 | 2019-04-26 | 湖北凌晟药业有限公司 | 一种盐酸头孢卡品酯中间体bcn的制备方法 |
CN111171050A (zh) * | 2020-03-20 | 2020-05-19 | 毛桃 | 一种盐酸头孢卡品酯的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105254649B (zh) | 2018-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105254649A (zh) | 一种盐酸头孢卡品酯的制备方法 | |
CN105131017B (zh) | 一种盐酸头孢卡品酯的制备方法 | |
CN104130273B (zh) | 一种头孢曲松钠的合成方法 | |
CN109575048B (zh) | 一种头孢噻肟钠的制备方法 | |
CN105061472A (zh) | 一种头孢曲松钠的一锅式合成方法 | |
CN101798313B (zh) | 一种头孢地尼的制备新方法 | |
CN105037393A (zh) | 一种氟氧头孢钠的制备方法 | |
CN102408440A (zh) | 盐酸头孢吡肟的合成方法 | |
CN109485658B (zh) | 一种头孢替唑酸的制备方法 | |
CN102643295B (zh) | 头孢米诺钠的制备方法 | |
CN102093390B (zh) | 一种制备头孢呋辛酸的方法 | |
CN102485727B (zh) | 一种盐酸头孢卡品酯及其中间体的制备方法 | |
CN103848851B (zh) | 一种盐酸头孢卡品酯的合成方法 | |
CN105198906A (zh) | 盐酸头孢卡品酯的制备方法 | |
CN103319503A (zh) | 一种头孢地尼的制备方法 | |
CN103360412B (zh) | 一种头孢羟氨苄的合成方法 | |
CN105859747B (zh) | 一种适于工业化生产的盐酸头孢吡肟的制备方法 | |
CN102617506B (zh) | 一种头孢地尼及其中间体的制备方法 | |
CN109517001B (zh) | 一种盐酸头孢替安的制备方法 | |
CN106317080A (zh) | 一种采用耦合结晶技术制备的头孢他啶化合物及其制剂 | |
CN105440054A (zh) | 一种制备高纯度头孢硫脒的工艺 | |
CN106220648A (zh) | 一种叔丁氧羰基头孢卡品酸二异丙胺盐的合成及纯化方法 | |
CN102911186B (zh) | 一种头孢唑肟钠的制备及精制方法 | |
CN102942575B (zh) | 一种头孢地嗪钠的制备方法 | |
CN108912145A (zh) | 一种α-特戊酰基头孢妥仑匹酯的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Man Wanhui Inventor after: Jin Lianming Inventor before: Chen Linghao |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180319 Address after: No. 1, Road No. 10, Xiangcheng Economic Development Zone, Xiangyang, Hubei Applicant after: HUBEI LINGSHENG PHARMACEUTICAL CO.,LTD. Address before: 1 residential building, No. 443 Changjiang East Road, Huangdao District, Shandong, China, 1708, China, 266520 Applicant before: QINGDAO CHENDA BIOLOGICAL SCIENCE & TECHNOLOGY Co.,Ltd. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 441048 Xiangcheng Economic Development Zone, Xiangcheng District, Xiangyang City, Hubei Province Patentee after: Hubei Lingsheng Pharmaceutical Co.,Ltd. Address before: 441141 No. 1, No. 10 road, Xiangcheng Economic Development Zone, Xiangyang City, Hubei Province Patentee before: HUBEI LINGSHENG PHARMACEUTICAL CO.,LTD. |
|
CP03 | Change of name, title or address | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of ceftriaxone hydrochloride ester Granted publication date: 20180626 Pledgee: Agricultural Bank of China Limited Xiangyang High tech Zone Branch Pledgor: Hubei Lingsheng Pharmaceutical Co.,Ltd. Registration number: Y2024980002009 |